1 – 3 of 3
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Cost-Effectiveness and Heterogeneity: Using Finite Mixtures of Disease Activity Models to Identify and Analyze Phenotypes
2015) In Working Paper / Department of Economics, School of Economics and Management, Lund University(
- Working paper/Preprint › Working paper
- 2010
-
Mark
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
(
- Contribution to journal › Article
- 2007
-
Mark
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades : A population-based study from Copenhagen, Denmark
(
- Contribution to journal › Article